Regens MD’s elite team of board-certified doctors and pharmacists excels in weight loss and metabolic health, providing effective prescriptions and ongoing support for real results.
Wegovy® and Ozempic® are trademarks owned by Novo Nordisk A/S.
Compounded Semaglutide is a medication prepared to order. While physicians may prescribe compounded medications in times of drug shortages, these are not regulated by the FDA for safety, efficacy, or quality. Learn about the compounding quality standards at Regens MD. There are also FDA-approved medications that contain semaglutide.
/month*
Same price at every dose
Having Regens MD by your side means you’ve discovered a genuine ally in your quest for weight loss.
Fill out your medical intake documents and get a quick online medical evaluation to see if you qualify for treatment, all without the need for a specific plan or program.
Every plan comes with a tailored medical evaluation, medication and supplies, care access, and learning materials, all without the need for plan or program fees.
Regens MD enables you to achieve your individual health objectives with frequent and ongoing online consultations, supported by an always-available care team.
*see policy for details
All-Inclusive Pricing: Program, Consultation, and Medications
Custom Formulaᴿˣ
What’s included?
/ month
Same low cost at every dose
FDA Approved for Weight Loss
What’s included?
/ month
Wegovy® is a trademark of Novo Nordisk A/S
FDA-approved for Type-2 Diabetes
What’s included?
/ month
Wegovy® is a trademark of Novo Nordisk A/S
Prescription items necessitate a virtual consultation with a qualified healthcare provider, who will exclusively decide if the prescription and treatment are suitable. Availability of treatments can vary. The advantages described on Regens MD rely on third-party assessments, where relevant. Medications might be provided through a subscription model, cancelable at any moment. Refer to policies for more information. Product packaging might differ from images. Outcomes can differ among individuals.
“Regens MD aims to deliver easy access to scientific, effective weight loss treatments and medical advice, ensuring safety and successful outcomes.”
VP of Pharmacy Operations, Regens MD
Only twelve percent of US adults are metabolically healthy.1
Nearly half the global population is currently trying to lose weight.2
After 68 weeks, participants administering once-weekly semaglutide treatment experienced an average of 15% reduction in body weight.3
Medication from FDA-regulated pharmacies, supplied with all essentials.
Included follow-up visits and free online access to a dedicated care team.
No pharmacy visits needed. Regens MD ships directly to you with free expedited and discreet packaging.
“I had my son in 2021 and struggled to lose weight… I was tired of having low self confidence and feeling like garbage all of the time, so I decided I wanted to try semaglutide. I’ve lost 45lbs so far and couldn’t be happier! This medication has been truly life changing for me!”
“I had my son in 2021 and struggled to lose weight… I was tired of having low self confidence and feeling like garbage all of the time, so I decided I wanted to try semaglutide. I’ve lost 45lbs so far and couldn’t be happier! This medication has been truly life changing for me!”
Discover our plans, complete your health history form, and receive personalized guidance from our board-certified physician.
Transparent pricing covers medication, consultation, and shipping for all dosages. Absolutely no hidden fees.
Continuous support from the beginning. We empower you to reach and exceed your personal health objectives every step of the way.
*see policy for details
There are no hidden or extra fees. Our programs include doctor visits, prescription medications, and free shipping.
Our affiliated doctors have the authority to prescribe a range of FDA-approved medications. This includes GLP-1 drugs like Wegovy® and semaglutide, as well as compounded medications such as acarbose, orlistat, naltrexone, and others if deemed medically suitable.
No insurance needed, we offer transparent out of pocket prices. What you see is what you pay!
Typically, we do not automatically enroll you in billing for weight loss medication plans. However, other products might offer auto-billing options if recommended by a physician for refill prescriptions. For inquiries regarding our billing procedures, please contact [email protected] for personalized assistance.
Regens MD ensures a flat pricing guarantee. Regardless of the dosage required for your treatment plan, the price remains consistent!
Our service is accessible for individuals in all 50 states, providing access to physicians and medication treatment plans.
The Regens MD team is with you every step of the way, dedicated to ensuring your journey is successful, effortless, and cost-effective. You’re never alone in this.
1. Ozempic®, a GLP-1 receptor agonist, is approved for improving blood sugar control in adults with type 2 diabetes when used alongside diet and exercise. Clinical trials showed it effectively lowers HbA1c and body weight, regardless of sex, race, or age. While offering significant benefits, it may cause side effects like gastrointestinal issues, with serious risks including pancreatitis and potential thyroid cancer based on animal studies. The drug’s efficacy and side effect profile were consistent across diverse demographic groups. Trials involved over 4,000 participants worldwide, further highlighting its global applicability and safety profile for a broad patient population.
2. In a comparative analysis, Semaglutide 2.4 mg emerged as a leading option for overweight or obese adults with or without diabetes, showcasing unparalleled efficacy in weight reduction and glycemic management against both GLP-1RAs and SGLT-2is. While its superior performance in lowering HbA1c, fasting plasma glucose, and blood pressure is noteworthy, it does come with a higher risk profile for adverse events. This underscores the need for careful consideration in clinical use, balancing Semaglutide’s potent benefits with its safety profile.
3. Semaglutide, a GLP-1 receptor agonist used in type 2 diabetes, significantly enhances glycemic control and reduces body weight compared to placebo and other antidiabetic agents. It demonstrates a notable reduction in HbA1c and body weight, with an average weight loss of -4.11 kg for the 1 mg dose. Despite its efficacy, semaglutide is associated with an increased occurrence of gastrointestinal side effects. Pancreatitis and diabetic retinopathy were less frequent, indicating that semaglutide’s benefits in managing type 2 diabetes extend to significant weight loss and improvement in blood pressure, with a necessity for further safety monitoring.
If you require a prescription item, Regens MD will assist in scheduling a consultation with a qualified healthcare provider. The provider will evaluate your eligibility for the prescription item. If deemed appropriate, a doctor may prescribe the item, which can be filled at a partner pharmacy unless you specify otherwise. Note: The statements above have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Essential Details About Our Products
© 2024 Regens MD Health International, Inc. All rights reserved
* Prescription products require an online evaluation with a licensed medical professional who will determine if a prescription is appropriate. See below for important safety information. Benefits outlined on Regens MD are based on 3rd party studies. Medication is offered as a subscription service which you can cancel at any time. Actual product packaging may appear differently than shown. Physicians may prescribe compounded medications as needed to meet patient requirements or drug shortages. The FDA does not review or approve any compounded medications for safety or effectiveness. Read more about Regens MD compounded quality standards here.
Should you seek a prescription item, Regens MD will facilitate arranging a consultation with a qualified healthcare provider. This professional will assess your suitability for the prescription item. If deemed suitable, a doctor may issue a prescription for the item, which can be filled at a partner pharmacy, unless you specify an alternative preference.
Note: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
